Judge Allows Mylan Execs to Revoke Fifth Amendment Plea
A federal judge in Connecticut ruled Mylan executives may waive their Fifth Amendment rights in two generic-drug price-fixing cases.
Updated on Oct. 27, 2026 in Law
Live Poll
Should defendants be allowed to revoke their invocation of the Fifth Amendment during ongoing legal trials?
A Connecticut federal judge has permitted Mylan executives to revoke their previous invocation of Fifth Amendment rights across two separate generic-drug price-fixing lawsuits. This ruling establishes a distinct procedural path for these two cases compared to a separate initial case already set for trial.
Why it matters
The decision marks a significant shift in how key witnesses in major antitrust litigation may choose to provide testimony. By allowing the revocation of these constitutional protections, the court is altering the evidentiary landscape for upcoming proceedings.
The ruling impacts two generic-drug price-fixing cases currently before the court. This comes after the court previously allowed state attorneys general to challenge the Fifth Amendment revocation in a separate, initial trial case.
The players
Mylan
Mylan is a pharmaceutical company involved in multiple generic-drug price-fixing cases in federal court.
The details
The federal court in Connecticut opted to handle the Fifth Amendment issue differently for the two newer cases than it did for the first case. While the first case allows state attorneys general to contest the move, the latest order clarifies the standards for the other two lawsuits.
Timeline
A federal judge issued the ruling on October 23, 2026.
Political Context
Opponents of this move argue that allowing witnesses to revoke their Fifth Amendment claims midway through litigation could undermine the integrity of the discovery process. Legal advocates for the states may push back, contending that the change in status disrupts the orderly progression of the trials.
This procedural shift may change how information about generic-drug pricing becomes public during the discovery phase. Residents of Connecticut and beyond should watch for further developments as these cases proceed through the federal court system.
The takeaway
The court's decision establishes a significant precedent for how defendants in complex antitrust cases manage their legal testimony. Parties involved in similar litigation should monitor how these specific revocations affect the overall trial strategy in the affected cases.
Further reading
For more information on ongoing legal proceedings in the state, visit the Law section.
Source note: This article includes information reported by Law360.
Live Poll
Should defendants be allowed to revoke their invocation of the Fifth Amendment during ongoing legal trials?
